Ectoenzymes in Epithelial Ovarian Carcinoma: Potential Diagnostic Markers and Therapeutic Targets

QR Code

Ectoenzymes in Epithelial Ovarian Carcinoma: Potential Diagnostic Markers and Therapeutic Targets

None

Saved in:

Bibliographic Details
Main Authors:	Buono, Nicola Lo, Morone, Simona, Parrotta, Rossella, Giacomino, Alice, Ortolan, Erika, Funaro, Ada
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/28405
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Controversies in the efficacy of adjuvant chemotherapy in different epithelial ovarian carcinoma histologies
by: Ece Esin, et al.
Published: (2019-12-01)

Markers of Primary Chemoresistance of Epithelial Ascites Cells in Patients with Ovarian Cancer Guidelines for Practitioners
by: D. R. Dolgova, et al.
Published: (2020-05-01)

EPITHELIAL OVARIAN CANCER. CLINICAL LECTURE
by: A. E. Solopova, et al.
Published: (2016-10-01)

Optimal cytoreduction for advanced epithelial ovarian cancer
by: N. G. Kormosh, et al.
Published: (2014-08-01)

The Prognostic Value of some Epithelial-Mesenchymal Transition Markers and Metastasis-Related Markers in Human Transitional Cell Carcinoma of the Bladder
by: Baghdad Science Journal
Published: (2018-09-01)

Tumour Budding with Epithelial Mesenchymal Transition Markers – A Novel Prognostic Tool for Breast Carcinoma
by: Priyadharshini Kumar, et al.
Published: (2025-04-01)

The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
by: Haiqi Su, et al.
Published: (2025-01-01)

A PILOT CLINICAL TRIAL TO MONITOR RESPONSE TO CHEMOTHERAPY USING THE CA-62 MARKER OF EPITHELIAL CARCINOMAS
by: G. G. Khakimova, et al.
Published: (2019-11-01)

PROGNOSIS OF THE RELAPSE OF OVARIAN CANCER BASED ON THE COMPUTER-ASSISTED MORPHOMETRIC STUDY OF OVARIAN CARCINOMA SAMPLES STAINED WITH VARIOUS HISTOCHEMICAL MARKERS
by: M. V. Sprindzuk, et al.
Published: (2019-06-01)

Manifestation of osteoblastic phenotypes in the sarcomatous component of epithelial carcinoma and sarcomatoid carcinoma
by: Yasutoshi Takashima, et al.
Published: (2017-06-01)

Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma
by: Nirmala Jagadish, et al.
Published: (2018-05-01)

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.
by: Madalene Earp, et al.
Published: (2018-01-01)

Epithelial-myoepithelial carcinoma of the lung: a case report
by: Yasuhiro Nakashima, et al.
Published: (2018-07-01)

NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
by: A. E. Solopova, et al.
Published: (2016-09-01)

The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression
by: Li-Li Wang, et al.
Published: (2017-05-01)

CXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancer
by: Yu-Jin Koo, et al.
Published: (2017-05-01)

Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models
by: Zihan Li, et al.
Published: (2025-07-01)

Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers
by: Pawel Sadlecki, et al.
Published: (2018-06-01)

Treatment results and prognostic factors of clear cell ovarian carcinomas and ovarian carcinomas with clear cell component
by: M. D. Ahmedova, et al.
Published: (2014-07-01)

PROGNOSTIC SIGNIFICANCE OF THE EPITHELIAL-MESENCHYMAL TRANSITION MARKERS AND MORPHOLOGICAL CHARACTERISTICS OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS IN THE DEVELOPMENT OF LYMPHOGENOUS METASTASES
by: V. A. Bychkov, et al.
Published: (2020-01-01)

CURRENT OPINIONS CONCERNING THE PATHOGENESIS OF EPITHELIAL OVARIAN CANCER AND NEW DIAGNOSTIC APPROACHES TO THE DISEASE
by: A. E. Solopova, et al.
Published: (2016-06-01)

Mass spectrometric profiling reveals association of -glycan patterns with epithelial ovarian cancer progression
by: Huanhuan Chen, et al.
Published: (2017-07-01)

Association of a common variant of gene with increased risk of serous epithelial ovarian cancer
by: Li Ma, et al.
Published: (2017-02-01)

Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis
by: İrem Öner, et al.
Published: (2025-06-01)

Identification of proteomic markers for metastasis of ovarian cancer
by: V. E. Shevchenko, et al.
Published: (2014-08-01)

ULTRASOUND CRITERIA OF EARLY DIAGNOSTICS OF OVARIAN CARCINOMA
by: L. A. Ashrafyan, et al.
Published: (2015-04-01)

Therapeutic potential of casticin in alleviating ovarian torsion/detorsion-induced ovarian and lung injuries
by: Ersen Eraslan, et al.
Published: (2025-08-01)

Sensitive Detection of Epithelial Ovarian Cancer Biomarkers Using Tag-Laser Induced Breakdown Spectroscopy
by: Markushin, Yuri, et al.
Published: (2012)

Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment
by: Efnan Algin, et al.
Published: (2016-08-01)

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity
by: Rachel M. Hurley, et al.
Published: (2025-06-01)

Gaillardin Impedes Human Ovarian Cancer Metastasis by Acting on Epithelial-Mesenchymal Transition and Angiogenic Factors
by: Sadegh Rajabi, et al.
Published: (2025-05-01)

Mendelian randomization analysis of CpG methylation and immune phenotypes in epithelial ovarian cancer outcomes
by: Jiawei Li, et al.
Published: (2025-12-01)

Hook1 inhibits malignancy and epithelial–mesenchymal transition in hepatocellular carcinoma
by: Xu Sun, et al.
Published: (2017-07-01)

Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer
by: A. V. Vorobev, et al.
Published: (2025-07-01)

High-Risk Factors and Therapeutic Advances in Ovarian Cancer
by: Xiaoyu SHA, et al.
Published: (2025-07-01)

Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues
by: Jan Tesarik
Published: (2025-04-01)

Unveiling the Diagnostic Significance of Calprotectin in Serous Ovarian Carcinoma
by: Alkis Matsas, et al.
Published: (2025-07-01)

Epithelial – mesenchymal transition markers, proliferation markers, and cytokine secretion in breast tissue in malignant and benign breast diseases
by: A. I. Autenshlyus, et al.
Published: (2024-01-01)

Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancer
by: Hang Xu, et al.
Published: (2025-07-01)

KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis
by: Long Huang, et al.
Published: (2017-06-01)